⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BMY

Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General

61.48USD

-1.5200 (-2.41%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BMY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 61.48
P/E13.5
Dvd Ind Yld4.1%
P/B5.63
P/S2.6
Curr EV/T12M EBITDA8.4
Mkt Cap (USD)125.6B
Curr EV (USD)159.6B
2)

Per Share Data

EPS T12M4.54
DPS2.49
Bk Val Per Sh10.93
Rev/Sh24.02
Cash/Sh5.42
Curr Shares Out2,042.7M
FCF/Sh5.59
3)

Cash Flow Analysis

P/CF9.8
Curr P/FCF11.0
CF/NI1.4
Dvd P/O54.9%
Cash Gen/Cash Reqd2.0
Csh Dvd Cov2.5
CFO/Sales26.0%
Eff Interest Rate3.7%
4)

Growth Potential

Dil EPS 1Y Gr178.5%
Cap 1Y Gr-3.6%
BPS 1Y Gr12.4%
R&D To Sales21.8%
Retention Rate45.1%
Rev 1Y Gr-0.2%
FCF 1Y Gr-7.9%
Assets 1Y Gr-2.8%
5)

Profitability

EBITDA18.9B
EBIT—
Operating Margin34.4%
Pretax Margin24.2%
Net Margin18.9%
ROA10.2%
ROE46.7%
ROC—
Asset Turnover0.54
6)

Structure

Current Ratio1.53
Quick Ratio1.29
Debt/Assets49.2%
Debt/Com Eq193.2%
Net Debt/EBITDA1.82
Tot Debt/Capital65.9%
Gross Margin70.2%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.